Knowlden et al. showed the cross-talk between IGF1R and EGFR signaling pathways occurred in tamoxifen-resistant MCF7 and T47D breast cancer cell-lines but not in non-resistant cells [18]. The gene discussed is EGFR; the disease is breast cancer.